Why Ultralife Corporation’s (ULBI) Stock Is Up 17.15%
As of Friday, August 07, Ultralife Corporation’s ULBI share price has surged by 17.15%, which has investors questioning if this is right time to sell.Michael Rose
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Michael Rose
Omar Beirat
Rosalio Madrigal
Rosalio Madrigal
Jenna Brashear
| Share Statistics | ULBI | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $114.1 | $730.3 | 23% |
|
| Shares Out (Mil) | 16.7 | 54.2 | 27% |
|
| Institutional Ownership | 43.7% | 73.1% | 19% |
|
| Float (Mil) | 9.6 | 55.3 | 19% |
|
| Beta | 0.80 | 1.23 | 48% |
|
| Avg Daily Volume (000s) | 61 | 447 | 30% |
|
| Price Change (52-week) |
3.0% | 48.9% | 47% |
|
| Growth | ULBI | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 12.2% | 9.5% | 66% |
|
| Net Income (5yr) | (25.7%) | (2.0%) | 16% |
|
| EPS (5yr) | (25.2%) | 10.4% | 10 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (5.6%) | (13.1%) | 61% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | ULBI | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $187 | $415 | 31% |
|
| Net Income (TTM) (Mil) | ($7) | ($2) | 32% |
|
| EPS (TTM) | ($0.393) | ($0.200) | 29% |
|
| Operating Cash Flow (TTM) (Mil) | $5 | ($2) | 36% |
|
| Net Cash Flow (TTM) (Mil) | ($4) | $10 | 34% |
|
| Long-Term Debt (Q1) (Mil) | $45 | $42 | 38% |
|
| Enterprise Value (Q1) (Mil) | $160 | $928 | 25% |
|
| Valuation | ULBI | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.86 | 3.50 | 17% |
|
| P/E | na | 34.5 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.4 | na |
|
| Ratios | ULBI | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 24.4% | 27.6% | 27% |
|
| Net Margin | (3.5%) | 0.1% | 27% |
|
| ROA | (3.0%) | (4.4%) | 33% |
|
| ROE | (4.8%) | 7.9% | 31% |
|
| Liabilities to Assets | 38.7% | 55.5% | 29% |
|
| F-Score | 3 | 4 | 18% |
|
Ultralife Corporation did not pass any screens on 8/20/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors